Interference of rheumatoid factor in competitive HIV assay

Low-dose aspirin prophylaxis to prevent hypertensive disorders of pregnancy after in vitro fertilisation: a scoping review protocol.

BMJ open·2024

Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024

[Decision-making process and evaluation of public health interventions].

Revue d'epidemiologie et de sante publique·2022

Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021

Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine.

Infectious diseases now·2020

Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Clinical characteristics of IgG4-related disease patients with different serum IgG4 levels: A single-center retrospective study.

The Journal of international medical research·2026

Angiotensin Type 1 Receptor Antibody Positivity in a Pediatric Liver Transplant Patient With Antibody-Mediated Rejection: A Case Report.

Pediatric transplantation·2026

Clinical characteristics and concordance of anti-MDA5 autoantibodies: A multicentre Australian study.

Arthritis care & research·2026

Longitudinal overview of symptomatic and immunosuppressive drugs in LEMS.

Journal of neuromuscular diseases·2026

Immunometabolic Dysregulation in Obesity: Integrating Macrophage Polarization, Metabolic Reprogramming, and Gut Microbiota Crosstalk.

Immunity, inflammation and disease·2026

Multisystem Hepatic Sarcoidosis With Hypereosinophilia and Elevated IgG4 Mimicking IgG4-Related Disease and Lymphoma: A Diagnostic Challenge.

Cureus·2026

Related Experiment Videos

Interference of rheumatoid factor in competitive HIV assay

Related Concept Videos

Low-dose aspirin prophylaxis to prevent hypertensive disorders of pregnancy after in vitro fertilisation: a scoping review protocol.

Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes.

[Decision-making process and evaluation of public health interventions].

Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?

Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine.

Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Clinical characteristics of IgG4-related disease patients with different serum IgG4 levels: A single-center retrospective study.

Angiotensin Type 1 Receptor Antibody Positivity in a Pediatric Liver Transplant Patient With Antibody-Mediated Rejection: A Case Report.

Clinical characteristics and concordance of anti-MDA5 autoantibodies: A multicentre Australian study.

Longitudinal overview of symptomatic and immunosuppressive drugs in LEMS.

Immunometabolic Dysregulation in Obesity: Integrating Macrophage Polarization, Metabolic Reprogramming, and Gut Microbiota Crosstalk.

Multisystem Hepatic Sarcoidosis With Hypereosinophilia and Elevated IgG4 Mimicking IgG4-Related Disease and Lymphoma: A Diagnostic Challenge.

Related Experiment Videos

Interference of rheumatoid factor in competitive HIV assay

Related Concept Videos

Related Articles